On the public citation graph
Systematic review and meta‐analysis: Association between liver fibrosis and subclinical atherosclerosis in nonalcoholic fatty liver disease
0 signed · 69 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/9780470712184openalex-snapshot
Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.1002/hep.1840200104openalex-snapshot
Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients With Chronic Hepatitis C
inferredcites →https://doi.org/10.1002/hep.25593openalex-snapshot
Nonalcoholic fatty liver disease is associated with coronary artery calcification
inferredcites →https://doi.org/10.1002/hep.25762openalex-snapshot
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
inferredcites →https://doi.org/10.1002/hep.29085openalex-snapshot
Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis
inferredcites →https://doi.org/10.1002/jgh3.12114openalex-snapshot
Association between non‐alcoholic fatty liver disease evaluated by transient elastography with extracranial carotid atherosclerosis in a multiethnic Asian community
inferredcites →https://doi.org/10.1007/s10620-019-05926-7openalex-snapshot
Early Predictors of Cardiovascular Disease Risk in Nonalcoholic Fatty Liver Disease: Non-obese Versus Obese Patients
inferredcites →https://doi.org/10.1007/s12072-020-10108-zopenalex-snapshot
Association of arterial stiffness with the histological severity of nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1016/j.atherosclerosis.2022.06.801openalex-snapshot
In patients with non-alcoholic fatty liver disease, liver stiffness directly correlates with the carotid plaque burden
inferredcites →https://doi.org/10.1016/j.cgh.2018.05.059openalex-snapshot
Magnetic Resonance vs Transient Elastography Analysis of Patients With Nonalcoholic Fatty Liver Disease: A Systematic Review and Pooled Analysis of Individual Participants
inferredcites →https://doi.org/10.1016/j.cgh.2019.05.003openalex-snapshot
Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes
inferredcites →https://doi.org/10.1016/j.jhep.2016.05.013openalex-snapshot
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
inferredcites →https://doi.org/10.1016/s2468-1253(22)00165-0openalex-snapshot
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1038/nature10146openalex-snapshot
Progress and challenges in translating the biology of atherosclerosis
inferredcites →https://doi.org/10.1038/s41575-018-0014-9openalex-snapshot
Noninvasive biomarkers in NAFLD and NASH — current progress and future promise
inferredcites →https://doi.org/10.1038/s41598-021-95581-8openalex-snapshot
Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.1093/ije/dyn065openalex-snapshot
Sensitivity of between-study heterogeneity in meta-analysis: proposed metrics and empirical evaluation
inferredcites →https://doi.org/10.1097/md.0000000000023360openalex-snapshot
Usefulness of controlled attenuation parameter and liver stiffness measurement for detecting increased arterial stiffness in asymptomatic populations in China
inferredcites →https://doi.org/10.1097/meg.0000000000000909openalex-snapshot
Increased arterial stiffness in nonalcoholic fatty liver disease: a systematic review and meta-analysis
inferredcites →https://doi.org/10.1097/meg.0000000000002375openalex-snapshot
Left ventricular strain predicts subclinical atherosclerosis in nonadvanced nonalcoholic fatty liver disease patients
inferredcites →https://doi.org/10.1111/apt.16324openalex-snapshot
Liver stiffness by magnetic resonance elastography is associated with increased risk of cardiovascular disease in patients with non‐alcoholic fatty liver disease
inferredcites →https://doi.org/10.1111/jgh.12992openalex-snapshot
Hepatic fibrosis assessed using transient elastography independently associated with coronary artery calcification
inferredcites →https://doi.org/10.1136/openhrt-2021-001850openalex-snapshot
Association between non-alcoholic fatty liver disease and subclinical atherosclerosis in Western and Asian cohorts: an updated meta-analysis
inferredcites →https://doi.org/10.1371/journal.pmed.1000100openalex-snapshot
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
inferredcites →https://doi.org/10.1371/journal.pone.0224184openalex-snapshot
Factors influencing subclinical atherosclerosis in patients with biopsy-proven nonalcoholic fatty liver disease
inferredcites →https://doi.org/10.14309/ctg.0000000000000504openalex-snapshot
The Ability of Lipoprotein (a) Level to Predict Early Carotid Atherosclerosis Is Impaired in Patients With Advanced Liver Fibrosis Related to Metabolic-Associated Fatty Liver Disease
inferredcites →https://doi.org/10.15557/jou.2018.0044openalex-snapshot
Multifocal fatty liver disease, insulin resistance and carotid atherosclerosis: exploring the interrelated relationship
inferredcites →https://doi.org/10.5114/pg.2021.109063openalex-snapshot
Association of non-alcoholic fatty liver disease with coronary artery calcification progression: a systematic review and meta-analysis
inferredcites →https://doi.org/10.53841/bpsicpr.2020.15.2.123openalex-snapshot
Cochrane Handbook for Systematic Reviews of Interventions
inferredcites →https://doi.org/10.5455/gulhane.39850openalex-snapshot
Non-alcoholic fatty liver disease per se is not associated with carotid atherosclerosis
inferredcites →https://doi.org/10.7326/0003-4819-151-4-200908180-00136openalex-snapshot
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4826078openalex-extracted
Liver Stiffness, Liver Function and Subsequent Metabolic Syndrome in NAFLD Associated Subclinical Atherosclerosis: Perspective from Mediation Analysis
inferred← citeshttps://doi.org/10.1002/alz.14033openalex-snapshot
The association between liver fibrosis score and incident dementia: A nationwide retrospective cohort study
inferred← citeshttps://doi.org/10.1002/hsr2.71530openalex-snapshot
Liver Fibrosis and Risk of Incident Dementia in the General Population: Systematic Review With Meta‐Analysis
inferred← citeshttps://doi.org/10.1007/s10554-024-03193-wopenalex-snapshot
Association of subclinical carotid artery atherosclerosis assessed by carotid ultrasound with nonalcoholic fatty liver disease fibrosis score in young and middle-aged men
inferred← citeshttps://doi.org/10.1007/s11892-024-01542-6openalex-snapshot
Metabolic dysfunction-associated steatotic liver disease and atherosclerosis
inferred← citeshttps://doi.org/10.1007/s12325-025-03121-xopenalex-snapshot
Liver-Kidney-Metabolic Health, Sex, and Menopause Impact Total Scores and Monovessel vs. Multivessel Coronary Artery Calcification
inferred← citeshttps://doi.org/10.1016/j.vph.2023.107249openalex-snapshot
Two sides of the same coin: Non-alcoholic fatty liver disease and atherosclerosis
inferred← citeshttps://doi.org/10.1038/s41598-025-31289-3openalex-snapshot
Time-updated FIB-4 index predicts coronary artery calcification progression in individuals with metabolic dysfunction–associated steatotic liver disease
inferred← citeshttps://doi.org/10.1038/s41598-025-88133-xopenalex-snapshot
Association of liver fibrosis with aneurysm size and mortality risk in patients undergoing open abdominal aortic aneurysm repair
inferred← citeshttps://doi.org/10.1080/00365521.2024.2364878openalex-snapshot
Noninvasive liver fibrosis markers are independently associated with carotid atherosclerosis risk in patients with nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1080/17474124.2024.2435504openalex-snapshot
MASLD: predictive value for liver-related events and extra-hepatic complications
inferred← citeshttps://doi.org/10.1093/eurheartj/ehae502openalex-snapshot
Cardiovascular disease assessment and management in liver transplantation
inferred← citeshttps://doi.org/10.1093/eurjpc/zwae306openalex-snapshot
Cardiovascular disease and metabolic dysfunction-associated steatotic liver disease: pathophysiology and diagnostic aspects
inferred← citeshttps://doi.org/10.1111/apt.17759openalex-snapshot
Letter: Are we forgetting the importance of steatosis in steatotic liver disease?
inferred← citeshttps://doi.org/10.1111/apt.17869openalex-snapshot
Systematic review with meta‐analysis: Steatosis severity and subclinical atherosclerosis in metabolic dysfunction‐associated steatotic liver disease
inferred← citeshttps://doi.org/10.1111/dom.16568openalex-snapshot
Metabolic dysfunction‐associated steatotic liver disease and sex‐specific risk of fatal and non‐fatal cardiovascular events: A meta‐analysis
inferred← citeshttps://doi.org/10.1161/hypertensionaha.124.24252openalex-snapshot
Impact of NAFLD and Fibrosis on Adverse Cardiovascular Events in Patients With Hypertension
inferred← citeshttps://doi.org/10.1161/jaha.124.040848openalex-snapshot
Association of Subclinical Liver Fibrosis With Death in Patients With Coronary Artery Disease: A Post Hoc Analysis of the ISCHEMIA Trial
inferred← citeshttps://doi.org/10.1177/1934578x251394620openalex-snapshot
Natural Products Ameliorate Non-Alcoholic Fatty Liver Disease and Atherosclerosis via the LKB1/AMPK Pathway
inferred← citeshttps://doi.org/10.1186/s12986-025-00951-yopenalex-snapshot
Liver fibrosis increases the risk of subclinical atherosclerosis in patients with MASLD: a cross-sectional and longitudinal study
inferred← citeshttps://doi.org/10.1186/s40001-025-03429-yopenalex-snapshot
Association between atherosclerosis-related indicators and fatty liver: a population-based observational study
inferred← citeshttps://doi.org/10.1186/s40001-026-04370-4openalex-snapshot
Association of metabolic dysfunction-associated steatotic liver disease markers and atherosclerotic disease burden
inferred← citeshttps://doi.org/10.1371/journal.pone.0301126openalex-snapshot
Steatotic liver disease and its newly proposed sub-classifications correlate with progression of the coronary artery calcium score
inferred← citeshttps://doi.org/10.14218/jtg.2023.00071openalex-snapshot
Liver Fibrosis as an Independent Cardiovascular Risk Factor in Non-alcoholic Fatty Liver Disease
inferred← citeshttps://doi.org/10.20517/mtod.2024.34openalex-snapshot
Perspective article: determinants and assessment of cardiovascular risk in steatotic liver disease owing to metabolic dysfunction-addressing the challenge
inferred← citeshttps://doi.org/10.3389/fmed.2024.1322102openalex-snapshot
Potential diagnostic markers shared between non-alcoholic fatty liver disease and atherosclerosis determined by machine learning and bioinformatic analysis
inferred← citeshttps://doi.org/10.3390/biom15020163openalex-snapshot
Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
inferred← citeshttps://doi.org/10.3390/jcm14082750openalex-snapshot
Metabolic Syndrome and Liver Disease: Re-Appraisal of Screening, Diagnosis, and Treatment Through the Paradigm Shift from NAFLD to MASLD
inferred← citeshttps://doi.org/10.3390/livers6050086openalex-snapshot
Current Insights into Liver Fibrosis: Epidemiological Patterns, Etiopathogenesis, Clinical Correlates, and Research Agenda
inferred← citeshttps://doi.org/10.3390/medicina60111781openalex-snapshot
From MASLD to PAD: Looking for Cardiovascular Disease Starting from Metabolic Status
inferred← citeshttps://doi.org/10.3390/nu17172759openalex-snapshot
Gut Dysbiosis and Plasma Trimethylamine Oxide Are Associated with Subclinical Coronary Atherosclerosis in Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease
inferred← citeshttps://doi.org/10.4070/kcj.2025.0212openalex-snapshot
Cardiovascular Implications in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): A State-of-the-Art Review
inferred← citeshttps://doi.org/10.4330/wjc.v17.i7.107751openalex-snapshot
Integrating liver and heart health: Cardiovascular risk reduction in patients with metabolic-associated steatotic liver disease
inferred← citeshttps://doi.org/10.53394/akd.2000342openalex-snapshot
Preprocedural Fibrosis-4 Index Is Independently Associated with Previous Cerebrovascular Events in Patients Undergoing Carotid Artery Stenting
inferred← citeshttps://doi.org/10.70322/fibrosis.2024.10006openalex-snapshot
Sex and Gender Differences in Liver Fibrosis: Pathomechanisms and Clinical Outcomes
inferred← citeshttps://doi.org/10.7759/cureus.46946openalex-snapshot
Uncovering the Cardiovascular Threat: A Comprehensive Examination of Liver Fibrosis and Subclinical Atherosclerosis in Non-alcoholic Fatty Liver Disease
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.